Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 1

In vivo attenuation of angiogenesis in hepatocellular carcinoma by Nigella sativa

Pages
178–186
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings might prove useful and helpful for the progression of therapies for hepatocarcinogenesis treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Angiogenesis is imperative in malignant tumor growth.
📊
Key Findings & Data:The aim of this study is to investigate the in vivo molecular mechanism underlying the antitumorproperties of Nigella sativa ethanolic extract (NSEE) through its antiangiogenic effect against diethyl nitrosamine (DENA)-inducedhepatocarcinogenesis.Materials and methods: Male Wistar rats were divided into 4 groups: normal, NSEE, DENA, and NSEE-DENA groups.
💡
Conclusion & Impact:These findings might prove useful and helpful for the progression of therapies for hepatocarcinogenesis treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Angiogenesis is imperative in malignant tumor growth. Hepatocellular carcinoma is a typical hypervasculartumor that relies on angiogenesis. The aim of this study is to investigate the in vivo molecular mechanism underlying the antitumorproperties of Nigella sativa ethanolic extract (NSEE) through its antiangiogenic effect against diethyl nitrosamine (DENA)-inducedhepatocarcinogenesis.Materials and methods: Male Wistar rats were divided into 4 groups: normal, NSEE, DENA, and NSEE-DENA groups. Final bodyweight, hepatosomatic indices, serum AFP, serum vascular endothelial growth factor (VEGF) levels, and liver tissue hepatocyte growthfactor β (HGFβ) protein expression were estimated. Liver sections were stained for histological examination. AFP levels with thehistological variations were chosen to confirm cancer development.Results: DENA significantly increased liver weight, hepatosomatic indices, serum AFP and VEGF levels, and liver HGFβ proteinexpression and significantly decreased final body weight. These effects were significantly reversed by NSEE. Furthermore, thehistopathological changes that appeared in rat livers due to DENA were reduced by NSEE without harmful effects when taken alone.Conclusion:The results of the present investigation provide evidence that the in vivo antiangiogenic effect of NSEE through downregulationof serum VEGF and liver HGFβ protein could be implicated in its antitumor activity. Its consumption has health benefits that favor livercancer management. These findings might prove useful and helpful for the progression of therapies for hepatocarcinogenesis treatment.

🔖

Cite This Article

FATHY, M., NIKAIDO, T. (2022). In vivo attenuation of angiogenesis in hepatocellular carcinoma by Nigella sativa. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 1, 178–186. https://ajindex.com/articles/610310

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Siveen KS, Prabhu K, Krishnankutty R, Kuttikrishnan S, Tsakou M, Alali FQ, Dermime S, Mohammad RM, Uddin S. Vascular endothelial growth factor (VEGF) signaling in tumour vascularization: potential and challenges. Curr Vasc Pharmacol 2017; 15: 339-351.
  2. Mueller MM, Fusenig NE. Friends or foes – bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839-849.
  3. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006; 10: 99-111.
  4. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
  5. Grothey A, Galanis E. Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 2009; 6: 507-518.
  6. Gonzalez-Moreno O, Lecanda J, Green JE, Segura V, Catena R, Serrano D, Calvo A. VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)- like cells via an autocrine loop. Exp Cell Res 2010; 316: 554- 567. Fujiuchi Y, Nagakawa O, Murakami K, Fuse H, Saiki I. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines. Oncol Rep 2003; 10: 1001-1006.
  7. Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res 2003; 63: 8351-8359. Finn RS. Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now? Clin Cancer Res 2010; 16: 390-397.
  8. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001; 94: 153- 156. Zhu AX. Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Oncologist 2006; 11: 790-800. Semenza GL. Angiogenesis in ischemic and neoplastic disorders. Ann Rev Med 2003; 54: 17-28.
  9. Jung JO, Gwak GY, Lim YS, Kim CY, Lee HS. Role of hepatic stellate cells in the angiogenesis of hepatoma. Korean J Gastroenterol 2003; 42: 142-148 (in Korean with an abstract in English). Hu X, Li S, He Y, Ai P, Wu S, Su Y, Li X, Cai L, Peng X. Antitumor and antimetastatic activities of a novel benzothiazole-2-thiol derivative in a murine model of breast cancer. Oncotarget 2017; 8: 11887-11895.
  10. Manzo A, Carillio G, Montanino A, Costanzo R, Sandomenico C, Rocco G, M